AIDS-RELATED PRIMARY EFFUSION LYMPHOMA
Clinical trials for AIDS-RELATED PRIMARY EFFUSION LYMPHOMA explained in plain language.
Never miss a new study
Get alerted when new AIDS-RELATED PRIMARY EFFUSION LYMPHOMA trials appear
Sign up with your email to follow new studies for AIDS-RELATED PRIMARY EFFUSION LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Gene therapy tackles HIV and lymphoma in one shot
Disease control OngoingThis early study tests whether giving gene therapy after standard chemotherapy is safe for people with AIDS-related non-Hodgkin lymphoma. The gene therapy adds anti-HIV genes to the patient's own blood stem cells, aiming to help the body fight HIV. Only 3 participants were enroll…
Matched conditions: AIDS-RELATED PRIMARY EFFUSION LYMPHOMA
Phase: PHASE1 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated Jun 27, 2026 08:00 UTC
-
Gene therapy trial aims to boost HIV fight in lymphoma patients
Disease control OngoingThis early-stage study tests whether giving gene therapy after chemotherapy is safe for people with AIDS-related non-Hodgkin lymphoma. The gene therapy adds special anti-HIV genes to the patient's own blood stem cells to help the body fight HIV. Ten participants will receive the …
Matched conditions: AIDS-RELATED PRIMARY EFFUSION LYMPHOMA
Phase: PHASE1 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated Jun 27, 2026 07:56 UTC